The project, which launched in September 2022 and was funded by Boehringer Ingelheim, has given subsidised respiratory pathogen investigations to over 300 farms so far.
The investigations revealed a mixture of agents, including: mycoplasma (37%), IBR (6%), P13 (12%), coronavirus (38%), histophilus (48%), RSV (30%), mannheimia (64%), and pasteurella (94%).
Following each investigation, discussions were held between farmer and vet about taking a more preventative approach, considering things like biosecurity, immunity, housing, environmental management, vaccination and treatment protocols.
CVS says the investigations have also enabled its vets to target the right vaccine to the right farm to cover the main risk periods for those animals.
Vaccinations have been timed in relation to peaks in clinical cases and pre-stress periods - such as weaning, group movements or transport to ensure animals are protected against the correct pathogen effectively.
CVS says that taking this preventative herd health measure has resulted in significantly fewer antibiotics being required to treat respiratory infection and disease in the past year.
Steven Carragher, Quality Improvement Farm Lead for CVS and Senior Veterinary Surgeon at Alnorthumbria Vets, said: “Though only running for just over two years, our programme is already yielding significant data, and we’re using this evidence to help each farm successfully implement a range of measures to help prevent and vaccinate against pneumonia – and to reduce antibiotic use.
Photo: www.depositphotos.com
PS: Whilst you're here, take a moment to see our latest job opportunities for vets.